- Home
- BRID
as 07-26-2024 4:00pm EST
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.
| Founded: | 1932 | Country: | United States |
| Employees: | N/A | City: | ANAHEIM |
| Market Cap: | 91.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 2.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.17 | EPS Growth: | -96.57 |
| 52 Week Low/High: | $9.79 - $12.78 | Next Earning Date: | 08-16-2024 |
| Revenue: | $236,660,000 | Revenue Growth: | -8.61% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Bridgford Foods Corporation (BRID)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bridgford Richard Eugene | BRID | Jun 12 '24 | Buy | $10.00 | 100 | $1,000.00 | 2,395 | SEC Form 4 | |
| Silva Juan Luis | BRID | Apr 1 '24 | Buy | $11.30 | 100 | $1,130.00 | 208 | SEC Form 4 | |
| Bridgford Richard Eugene | BRID | Mar 18 '24 | Buy | $10.62 | 195 | $2,070.90 | 2,295 | SEC Form 4 | |
| Bridgford Allan Jr. | BRID | Mar 15 '24 | Buy | $10.77 | 82 | $883.14 | 42,831 | SEC Form 4 | |
| Bridgford Allan Jr. | BRID | Mar 15 '24 | Buy | $10.75 | 134 | $1,440.50 | 42,965 | SEC Form 4 | |
| Bridgford Allan Jr. | BRID | Mar 13 '24 | Buy | $11.39 | 15 | $170.85 | 43,000 | SEC Form 4 | |
| Bridgford Allan Jr. | BRID | Mar 13 '24 | Buy | $10.50 | 20 | $210.00 | 42,985 | SEC Form 4 | |
| Bridgford Allan Jr. | BRID | Mar 13 '24 | Buy | $10.40 | 233 | $2,423.20 | 42,234 | SEC Form 4 | |
| Bridgford Richard Eugene | BRID | Mar 13 '24 | Buy | $10.62 | 200 | $2,124.00 | 2,100 | SEC Form 4 | |
| Robbins Travis | BRID | Sep 1 '23 | Buy | $11.53 | 89 | $1,026.17 | 89 | SEC Form 4 | |
| Robbins Travis | BRID | Sep 1 '23 | Buy | $11.23 | 98 | $1,100.54 | 187 | SEC Form 4 |
Latest Bridgford Foods Corporation News
BRID Breaking Stock News: Dive into BRID Ticker-Specific Updates for Smart Investing
Associated Press Finance
2 months ago
Bridgford: Fiscal Q2 Earnings Snapshot
Associated Press Finance
5 months ago
Bridgford: Fiscal Q1 Earnings Snapshot
GlobeNewswire
6 months ago
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Thomson Reuters StreetEvents
6 months ago
Q2 2024 Accuray Inc Earnings Call
Zacks
6 months ago
Accuray (ARAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Simply Wall St.
6 months ago
Here's What We Like About Orrstown Financial Services' (NASDAQ:ORRF) Upcoming Dividend
Business Wire
6 months ago
Redwire Expands Footprint in Colorado with Opening of New Manufacturing and Testing Facility to Ramp Up Production of National Security Space Hardware
GlobeNewswire
6 months ago
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
Compare BRID vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRID Bridgford Foods Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.